✦ LIBER ✦

25 The use of EBV-specific cytotoxic T lymphocytes as adjuvant therapy post stem cell transplant for relapsed EBV-positive Hodgkin disease

✍ Scribed by C.M. Bollard; K.C. Straathof; H. Huls; K. Lacuesta; M.V. Gresik; G. Carrum; M.K. Brenner; C.M. Rooney; H.E. Heslop

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The use of autologous LMP2-specific cyto

✍ C.M. Bollard; K.C. Straathof; H. Huls; V. Gresik; G. Carrum; S. Gottschalk; A. G 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 55 KB

The clinical use of LMP2-specific cytoto

✍ C.M. Bollard; E. Buza; H. Huls; T. Lopez; V. Gresik; J. Chang; S. Gottschalk; G. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 67 KB